Related Experiment Videos
Lymphocytes, cytokines, inflammation, and immune trafficking
1Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC 20307-5001.
Current Opinion in Rheumatology
|September 1, 1994
Summary
Systemic lupus erythematosus involves immune cell defects, including T cells and antigen-presenting cells, leading to autoantibody production and clinical disease. Understanding molecular defects in these cells is key to unraveling lupus pathogenesis.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Systemic lupus erythematosus (SLE) is characterized by diverse immune cell abnormalities.
- These abnormalities are increasingly linked to specific molecular defects.
Purpose of the Study:
- To elucidate the role of T cells in SLE pathogenesis.
- To investigate the function of antigen-presenting cells (APCs) in SLE.
- To understand the impact of aberrant adhesion molecule expression in SLE.
Main Methods:
- Characterization of T cell receptor expression and lymphokine production.
- Assessment of T cell help for B cell autoantibody production.
- Study of APC antigen presentation and costimulation of T cells.
- Analysis of adhesion molecule expression patterns.
Main Results:
- T cells show abnormal T cell receptor expression and inappropriate lymphokine production.
- T cells provide aberrant help to B cells, promoting autoantibody generation.
- APCs exhibit altered antigen presentation and costimulation capabilities.
- Aberrant adhesion molecule expression is observed, potentially driving tissue responses.
Conclusions:
- Molecular defects in immune cells, particularly T cells and APCs, are central to SLE pathogenesis.
- Understanding these cellular and molecular abnormalities is crucial for explaining autoantibody production and clinical manifestations.
- Aberrant adhesion molecule expression may contribute to the tissue-specific pathology seen in SLE.